Suppr超能文献

我们如何创建并完善证据基础?

How do we create, and improve, the evidence base?

作者信息

Innes N P T, Schwendicke F, Lamont T

机构信息

Dundee Dental School, University of Dundee, Park Place, Dundee, Tayside, DD1 4HR.

Department of Operative and Preventive Dentistry, Charité-Universitätsmedizin, Aβmannshauser Str. 4-6, 14197 Berlin, Germany.

出版信息

Br Dent J. 2016 Jun 24;220(12):651-5. doi: 10.1038/sj.bdj.2016.451.

Abstract

Providing best clinical care involves using the best available evidence of effectiveness to inform treatment decisions. Producing this evidence begins with trials and continues through synthesis of their findings towards evidence incorporation within comprehensible, usable guidelines, for clinicians and patients at the point of care. However, there is enormous wastage in this evidence production process, with less than 50% of the published biomedical literature considered sufficient in conduct and reporting to be fit for purpose. Over the last 30 years, independent collaborative initiatives have evolved to optimise the evidence to improve patient care. These collaborations each recommend how to improve research quality in a small way at many different stages of the evidence production and distillation process. When we consider these minimal improvements at each stage from an 'aggregation of marginal gains' perspective, the accumulation of small enhancements aggregates, thereby greatly improving the final product of 'best available evidence'. The myriad of tools to reduce research quality leakage and evidence loss should be routinely used by all those with responsibility for ensuring that research benefits patients, that is, those who pay for research (funders), produce it (researchers), take part in it (patients/participants) and use it (clinicians, policy makers and service commissioners).

摘要

提供最佳临床护理需要运用现有的最佳有效性证据来指导治疗决策。生成这些证据始于试验,并通过对试验结果进行综合,直至将证据纳入易于理解且实用的指南,供临床医生和患者在护理点使用。然而,在这个证据生成过程中存在大量浪费,不到50%的已发表生物医学文献在研究开展和报告方面被认为足以满足实际需求。在过去30年里,独立的合作倡议不断发展,以优化证据从而改善患者护理。这些合作各自建议如何在证据生成和提炼过程的许多不同阶段以小幅度方式提高研究质量。当我们从“边际收益汇总”的角度考虑每个阶段的这些微小改进时,小改进的积累会产生累加效应,从而极大地改善“最佳可用证据”的最终成果。所有负责确保研究造福患者的人员,即那些为研究付费的人(资助者)、开展研究的人(研究人员)、参与研究的人(患者/参与者)以及使用研究成果的人(临床医生、政策制定者和服务专员),都应常规使用各种减少研究质量流失和证据损失的工具。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验